TPCW
GMAB icon

TD Private Client Wealth’s Genmab GMAB Stock Holding History

TD Private Client Wealth’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120K Sell
4,376
-824
-16% -$21.9K ﹤0.01% 744
2026
Q1 		$140K Sell
5,200
-3,160
-38% -$94.7K ﹤0.01% 713
2025
Q4 		$257K Buy
8,360
+893
+12% +$27.8K 0.01% 610
2025
Q3 		$229K Buy
7,467
+1,159
+18% +$28.2K 0.01% 634
2025
Q2 		$130K Sell
6,308
-1,759
-22% -$36.1K ﹤0.01% 707
2025
Q1 		$158K Sell
8,067
-3,481
-30% -$73K ﹤0.01% 647
2024
Q4 		$241K Sell
11,548
-268
-2% -$5.89K 0.01% 565
2024
Q3 		$288K Sell
11,816
-2,038
-15% -$54.5K 0.01% 539
2024
Q2 		$348K Buy
13,854
+71
+0.5% +$2.01K 0.01% 490
2024
Q1 		$412K Buy
13,783
+1,100
+9% +$32.3K 0.01% 473
2023
Q4 		$404K Buy
12,683
+7,737
+156% +$243K 0.01% 464
2023
Q3 		$174K Buy
4,946
+2,718
+122% +$104K 0.01% 570
2023
Q2 		$84.7K Buy
2,228
+360
+19% +$14.4K ﹤0.01% 689
2023
Q1 		$70.5K Sell
1,868
-3,728
-67% -$143K ﹤0.01% 702
2022
Q4 		$237K Buy
5,596
+321
+6% +$13.2K 0.01% 524
2022
Q3 		$169K Buy
5,275
+4,173
+379% +$147K 0.01% 550
2022
Q2 		$35.8K Sell
1,102
-3,090
-74% -$100K ﹤0.01% 798
2022
Q1 		$152K Buy
4,192
+1,141
+37% +$39.2K 0.01% 581
2021
Q4 		$121K Buy
3,051
+853
+39% +$35.6K 0.01% 612
2021
Q3 		$96.1K Buy
2,198
+134
+6% +$6.02K ﹤0.01% 634
2021
Q2 		$84.3K Buy
2,064
+1,438
+230% +$55.5K ﹤0.01% 639
2021
Q1 		$20.6K Buy
626
+17
+3% +$639 ﹤0.01% 823
2020
Q4 		$24.8K Sell
609
-361
-37% -$13.5K ﹤0.01% 754
2020
Q3 		$35.5K Buy
970
+957
+7,362% +$34.6K ﹤0.01% 659
2020
Q2 		$441 Sell
13
-3,063
-100% -$83.5K ﹤0.01% 1038
2020
Q1 		$65.2K Buy
3,076
+412
+15% +$9.18K ﹤0.01% 546
2019
Q4 		$59.5K Buy
+2,664
New +$58.1K ﹤0.01% 583

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

TD Private Client Wealth's GMAB Position: Q2 2026 in Review

TD Private Client Wealth reduced its Genmab (GMAB) stake by 16% in Q2 2026, selling an estimated $21.9K and leaving 4,376 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #744.

TD Private Client Wealth first reported a position in GMAB in Q4 2019 and has held it in 27 quarters since. The position peaked at $412K in Q1 2024. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • TD Private Client Wealth held 4,376 shares of Genmab worth $120K as of Q2 2026.
  • TD Private Client Wealth sold 824 Genmab shares in Q2 2026, an estimated $21.9K.
  • Genmab made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #744 holding.
  • TD Private Client Wealth first reported a position in Genmab in Q4 2019 and has held it in 27 quarters since.
  • TD Private Client Wealth's Genmab position peaked at $412K in Q1 2024.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.